Altre lingue GeneDx Holdings Corp.

Azioni

WGS

US81663L2007

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 19/04/2024			Variaz. 5gg	Var. 1 gen.
9,64 ^USD	+0,73%		+0,21%	+250,55%

15/04	GENEDX HOLDINGS CORP. : per Goldman Sachs il titolo è Neutral	ZM
20/02	Transcript : GeneDx Holdings Corp., Q4 2023 Earnings Call, Feb 20, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024	04/04
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics	14/03
GeneDx to Participate in 44th Annual Cowen Health Care Conference	26/02
Health Care Down on a Mixed Growth View -- Health Care Roundup	21/02
Earnings Flash (WGS) GENEDX HOLDINGS Posts Q4 Revenue $57.4M	20/02
GeneDx Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	20/02
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024	20/02
GeneDx Holdings Corp. Provides Earnings Guidance for the Full Year of 2024	20/02
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024	01/02
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	24/01
GeneDx Shares Gain After Preliminary Q4 Revenue Outlook	08/01
GeneDx Announces Preliminary 2023 Financial Results	08/01
Genedx Holdings Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023	08/01
GeneDx Holdings Corp.(NasdaqGS:WGS) dropped from S&P Global BMI Index	18/12
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy	01/12
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference	28/11
Thinking about buying stock in Turnstone Biologics, Iterum Therapeutics, New Gold, GeneDx Holdings, or Tempest Therapeutics?	27/11
Genedx Holdings Insider Bought Shares Worth $161,368, According to a Recent SEC Filing	20/11
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	20/11
Genedx Holdings Insider Sold Shares Worth $1,140,027, According to a Recent SEC Filing	17/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue GeneDx Holdings Corp.

Azioni

WGS

US81663L2007

Altre lingue

Filtri